虚血性急性臓器不全に対するATP-MgCl_2療法 (2007)
平澤, 博之, 大川, 昌権, 小高, 通夫, 佐藤, 博, ヒラサワ, ヒロユキ, Hirasawa, Hiroyuki, ...
Shock, sepsis等critical conditionのもとでは,心,肺,肝,腎等重要臓器への血流の減少,及びそれにともなう酸素やenergy...
母児ともに救命しえた妊娠36週HELLP症候群の1症例 : 緊急帝王切開にて胎児を救命し術後肝不全,腎不全,DIC,腹膜炎および急性C型肝炎を併発し重篤な経過をとった症例 (2007)
山口, 治見, 稲葉, 憲之, 深沢, 一雄, 高野, 始, 高見澤, 裕吉, 平澤, 博之, ...
われわれは妊娠36週でHELLP症候群と診断し,緊急帝王切開術を施行し,母児ともに救命しえた1例を経験したので報告する。症例は27歳,初産婦。妊娠34週6...
Teraoka, Tomohisa, Sugai, Takao, Nakamura, Sunao, Hirasawa, Hiroyuki, Oda, Shigeto, Shiga, Hidetoshi, ...
Background. In clinical studies, it has been difficult to evaluate the influence of haemodialysis (HD) parameters on HD clearance (CLHD) and reduction rate (RR) of non-ionic contrast medium during HD...
Teraoka, Tomohisa, Sugai, Takao, Nakamura, Sunao, Hirasawa, Hiroyuki, Oda, Shigeto, Shiga, Hidetoshi, ...
Background. In clinical studies, it has been difficult to evaluate the influence of haemodialysis (HD) parameters on HD clearance (CLHD) and reduction rate (RR) of non-ionic contrast medium during HD...
Teraoka, Tomohisa, Sugai, Takao, Nakamura, Sunao, Hirasawa, Hiroyuki, Oda, Shigeto, Shiga, Hidetoshi, ...
Background. In clinical studies, it has been difficult to evaluate the influence of haemodialysis (HD) parameters on HD clearance (CLHD) and reduction rate (RR) of non-ionic contrast medium during HD...
Hoshino, Masami, Haraguchi, Yoshikura, Hirasawa, Hiroyuki, Sakai, Motohiro, Saegusa, Hiroshi, Hayashi, Kazushiro, ...
Abstract Background Glucose tolerance (GT) has not been taken into consideration in investigations concerning relationships between coagulopathy and multiple organ dysfunction syndrome (MODS), and...
織田, 成人, オダ, シゲト, Oda, Shigeto, 平澤, 博之, ヒラサワ, ヒロユキ, Hirasawa, Hiroyuki, ...
Continuous hemofiltration/hemodiafiltration in critical care
志賀, 英敏, Shiga, Hidetoshi, Nakanishi, Kazuya, Matsuda, Ken-ichi, Nakamura, Masataka, 平澤, 博之, ...
志賀, 英敏, Shiga, Hidetoshi, Nakanishi, Kazuya, Matsuda, Ken-ichi, Nakamura, Masataka, Ikeda, Hiroyuki, ...
平澤, 博之, ヒラサワ, ヒロユキ, Hirasawa, Hiroyuki, 織田, 成人, オダ, シゲト, Oda, Shigeto, ...
織田, 成人, オダ, シゲト, Oda, Shigeto, 平澤, 博之, ヒラサワ, ヒロユキ, Hirasawa, Hiroyuki, ...
Continuous hemofiltration/hemodiafiltration in critical care
志賀, 英敏, Shiga, Hidetoshi, Nakanishi, Kazuya, Matsuda, Ken-ichi, Nakamura, Masataka, 平澤, 博之, ...
志賀, 英敏, Shiga, Hidetoshi, Nakanishi, Kazuya, Matsuda, Ken-ichi, Nakamura, Masataka, Ikeda, Hiroyuki, ...
平澤, 博之, ヒラサワ, ヒロユキ, Hirasawa, Hiroyuki, 織田, 成人, オダ, シゲト, Oda, Shigeto, ...
Hoshino, Masami, Haraguchi, Yoshikura, Hirasawa, Hiroyuki, Sakai, Motohiro, Saegusa, Hiroshi, Hayashi, Kazushiro, ...
Hoshino, Masami, Haraguchi, Yoshikura, Hirasawa, Hiroyuki, Mizushima, Iwanori, Tanaka, Chie, Morita, Yasumasa, ...
Seven non-septic and twenty-two septic ICU patients with glucose intolerance were investigated by using bedside-type artificial pancreas (AP). IC was measured by the glucose clamp method (GC) in...
Hoshino, Masami, Haraguchi, Yoshikura, Hirasawa, Hiroyuki, Mizushima, Iwanori, Tanaka, Chie, Morita, Yasumasa, ...
Seven non-septic and twenty-two septic ICU patients with glucose intolerance were investigated by using bedside-type artificial pancreas (AP). IC was measured by the glucose clamp method (GC) in...
Hoshino, Masami, Haraguchi, Yoshikura, Hirasawa, Hiroyuki, Sakai, Motohiro, Saegusa, Hiroshi, Hayashi, Kazushiro, ...
織田, 成人, オダ, シゲト, Oda, Shigeto, 平澤, 博之, ヒラサワ, ヒロユキ, Hirasawa, Hiroyuki, ...
Continuous hemofiltration/hemodiafiltration in critical care
志賀, 英敏, Shiga, Hidetoshi, Nakanishi, Kazuya, Matsuda, Ken-ichi, Nakamura, Masataka, 平澤, 博之, ...
志賀, 英敏, Shiga, Hidetoshi, Nakanishi, Kazuya, Matsuda, Ken-ichi, Nakamura, Masataka, Ikeda, Hiroyuki, ...
平澤, 博之, ヒラサワ, ヒロユキ, Hirasawa, Hiroyuki, 織田, 成人, オダ, シゲト, Oda, Shigeto, ...
Hoshino, Masami, Haraguchi, Yoshikura, Hirasawa, Hiroyuki, Mizushima, Iwanori, Tanaka, Chie, Morita, Yasumasa, ...
Seven non-septic and twenty-two septic ICU patients with glucose intolerance were investigated by using bedside-type artificial pancreas (AP). IC was measured by the glucose clamp method (GC) in...
ICU入室患者における遊離顆粒球elastase血中濃度測定の意義の検討
松田, 兼一, 織田, 成人, 平澤, 博之, ヒラサワ, ヒロユキ, Hirasawa, Hiroyuki, 菅井, 桂雄, ...
ICU入室患者における遊離顆粒球elastase血中濃度測定の意義の検討
松田, 兼一, 織田, 成人, 平澤, 博之, ヒラサワ, ヒロユキ, Hirasawa, Hiroyuki, 菅井, 桂雄, ...
上野, 博一, 平澤, 博之, ヒラサワ, ヒロユキ, Hirasawa, Hiroyuki, 菅井, 桂雄, 大竹, 喜雄, ...
第9回千葉県MOF研究会
川上, 雅之, 平澤, 博之, ヒラサワ, ヒロユキ, Hirasawa, Hiroyuki, 菅井, 桂雄, 織田, 成人, ...
劇症肝炎(fulminant hepatitis; FH)に対する肝移植の適応の検討
横張, 賢司, 平澤, 博之, ヒラサワ, ヒロユキ, Hirasawa, Hiroyuki, 菅井, 桂雄, 織田, 成人, ...
川上, 雅之, 平澤, 博之, ヒラサワ, ヒロユキ, Hirasawa, Hiroyuki, 菅井, 桂雄, 織田, 成人, ...
劇症肝炎(fulminant hepatitis; FH)に対する肝移植の適応の検討
横張, 賢司, 平澤, 博之, ヒラサワ, ヒロユキ, Hirasawa, Hiroyuki, 菅井, 桂雄, 織田, 成人, ...
持続的血液濾過透析(CHDF)のnon-renal indication
織田, 成人, オダ, シゲト, Oda, Shigeto, 平澤, 博之, ヒラサワ, ヒロユキ, Hirasawa, Hiroyuki, ...
持続的血液濾過透析(CHDF)のnon-renal indication
織田, 成人, オダ, シゲト, Oda, Shigeto, 平澤, 博之, ヒラサワ, ヒロユキ, Hirasawa, Hiroyuki, ...
胃粘膜内pH (gastric pHi)を用いた重症患者における組織酸素代謝の検討
平澤, 博之, ヒラサワ, ヒロユキ, Hirasawa, Hiroyuki, HIRASAWA, Hiroyuki, 菅井, 桂雄, 大竹, 喜雄, ...
胃粘膜内pH (gastric pHi)を用いた重症患者における組織酸素代謝の検討
平澤, 博之, ヒラサワ, ヒロユキ, Hirasawa, Hiroyuki, HIRASAWA, Hiroyuki, 菅井, 桂雄, 大竹, 喜雄, ...
外科領域のSIRS (systemic inflammatory response syndrome)
平澤, 博之, ヒラサワ, ヒロユキ, Hirasawa, Hiroyuki, HIRASAWA, HIROYUKI, 菅井, 桂雄, 織田, 成人, ...
外科領域のSIRS (systemic inflammatory response syndrome)
平澤, 博之, ヒラサワ, ヒロユキ, Hirasawa, Hiroyuki, HIRASAWA, HIROYUKI, 菅井, 桂雄, 織田, 成人, ...
Continuous Hemodiafiltration with PMMA Hemofilter in the Treatment of Patients with Septic Shock
Nakada, Taka-aki, Oda, Shigeto, Matsuda, Ken-ichi, Sadahiro, Tomohito, Nakamura, Masataka, Abe, Ryuzo, ...
Septic shock is the most severe form of sepsis. It is widely accepted that cytokines play pivotal roles in the pathophysiology of septic shock. We reported previously that continuous...
Blood glucose control in patients with severe sepsis and septic shock
Hirasawa, Hiroyuki, Oda, Shigeto, Nakamura, Masataka
The main pathophysiological feature of sepsis is the uncontrollable activation of both pro- and anti-inflammatory responses arising from the overwhelming production of mediators such as pro- and...